Unresectable Metastatic Colon Cancer

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2020-10-19
Clinical Trial Update: A Study of Bevacizumab, Infusional Fluorouracil, Leucovorin, Oxaliplatin, and Irinotecan (A-FOLFOXIRI) Compared With Bevacizumab, Infusional Fluorouracil, Leucovorin, and Irinotecan/Oxaliplatin (A-FOLFIRI/FOLFOX) as First-line Treatment for Metastatic Right-sided Colon Cancer [Phase 2]
Phase 2 trial comparing A-FOLFOXIRI vs A-FOLFIRI/FOLFOX as first-line treatment for unresectable metastatic right-sided colon cancer.